Clinical Trial Update: Consistency of Response With Rimegepant in Acute Treatment of Migraine

View source ↗

Summary

Pfizer's ongoing trial on rimegepant for acute migraine reports data on the consistency of patient response; the study status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Nurtec ODT (rimegepant) (rimegepant)

Snippet

Sponsor: Pfizer | Conditions: Migraine | Status: ACTIVE_NOT_RECRUITING